4.7 Article

Predictors of re-attempt in a cohort of suicide attempters: A survival analysis

期刊

JOURNAL OF AFFECTIVE DISORDERS
卷 247, 期 -, 页码 20-28

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jad.2018.12.050

关键词

Suicide; Phsychopharmaology; Prevention

资金

  1. Instituto de Salud Carlos III [ISCIII PI13/02200, PI16/01852]
  2. Delegacion del Gobierno para el Plan Nacional de Drogas [20151073]
  3. American Foundation for Suicide Prevention (AFSP) [LSRG-1-005-16]

向作者/读者索取更多资源

Background: Suicide prevention is one of the greatest challenges in mental health policies. Since a previous suicide attempt is the main predictor of future suicidal behaviour, clinical management of suicide attempters is vital for lowering mortality. Psychopharmacological interventions are still nonspecific, and their effectiveness have often been questioned. In this study, we aim to identify predictors of suicide re-attempt in a cohort of suicide attempters, with particular focus on different aspects of psychopharmacological treatment. Methods: This is a prospective study. Adults presenting with a suicide attempt were approached to take part in our study, resulting in a final sample of 371 participants. Participants were followed from inclusion to next suicide attempt, death by other causes, loss of the patient, or after a maximum of two years. We conducted Kaplan-Meier survival analyses and a multivariate Cox regression model for several exposure variables. Results: During the study period, 70 participants (18,9%) re-attempted. 60% of re-attempts occurred within the first 6 months. Three factors were independently associated with risk of re-attempt in the Multivariate Cox regression model: diagnosis of a Cluster B personality disorder, good treatment compliance, and at least one previous suicide attempt prior to the index event. Limitations: Indication bias precludes a clear interpretation of our results regarding psychopharmacological treatment. Poor adherence may also be a consequence of relapse rather than just one of its causes. Conclusions: A correct psychopharmacological treatment is insufficient to prevent re-attempts in populations at risk. Strategies to increase compliance should be taken into account as part of prevention programs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据